Lv5
1050 积分 2026-01-11 加入
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
10天前
已完结
Facile induction of immune tolerance by an interleukin-2–TGFβ surrogate agonist
17天前
已完结
The Glycosylation and Pharmacokinetics of CTLA4Ig Produced in Rice Cells
24天前
已完结
The Impact of Glycosylation on the Pharmacokinetics of a TNFR2:Fc Fusion Protein Expressed in Glycoengineered Pichia Pastoris
24天前
已完结
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
1个月前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
1个月前
已完结
Artificial intelligence in drug development
2个月前
已完结
Review Article: TL1A Inhibitors in IBD ‐ Mechanistic Rationale and Clinical Evidence
3个月前
已完结
Chemically induced mouse models of acute and chronic intestinal inflammation
4个月前
已完结
Comprehensive research on the distribution of HLA‐DRB1 in Chinese populations
5个月前
已完结
皖公网安备34019202002308
